HANDOK Inc. (002390.KS)

KRW 12270.0

(-2.54%)

Long Term Debt Summary of HANDOK Inc.

  • HANDOK Inc.'s latest annual long term debt in 2023 was 123.78 Billion KRW , down -33.28% from previous year.
  • HANDOK Inc.'s latest quarterly long term debt in 2024 Q2 was 168.63 Billion KRW , up 18.14% from previous quarter.
  • HANDOK Inc. reported annual long term debt of 185.53 Billion KRW in 2022, up 33.02% from previous year.
  • HANDOK Inc. reported annual long term debt of 139.47 Billion KRW in 2021, down -9.51% from previous year.
  • HANDOK Inc. reported quarterly long term debt of 168.63 Billion KRW for 2024 Q2, up 18.14% from previous quarter.
  • HANDOK Inc. reported quarterly long term debt of 123.78 Billion KRW for 2023 Q4, down -24.68% from previous quarter.

Annual Long Term Debt Chart of HANDOK Inc. (2023 - 2007)

Historical Annual Long Term Debt of HANDOK Inc. (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 123.78 Billion KRW -33.28%
2022 185.53 Billion KRW 33.02%
2021 139.47 Billion KRW -9.51%
2020 154.13 Billion KRW 64.06%
2019 93.94 Billion KRW 86.89%
2018 50.27 Billion KRW -52.25%
2017 105.26 Billion KRW 17.7%
2016 89.43 Billion KRW 45.44%
2015 61.49 Billion KRW 13.83%
2014 54.02 Billion KRW 170.12%
2013 20 Billion KRW 0.0%
2012 20 Billion KRW 0.0%
2011 - KRW 0.0%
2010 - KRW 0.0%
2009 - KRW 0.0%
2008 - KRW 0.0%
2007 - KRW 0.0%

Peer Long Term Debt Comparison of HANDOK Inc.

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW -807.477%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 38.741%
Ildong Holdings Co., Ltd. 29.87 Billion KRW -314.305%
Kukje Pharma Co., Ltd. 475.74 Million KRW -25918.318%
Yuhan Corporation 60.23 Billion KRW -105.5%
Dong-A ST Co., Ltd. 161.99 Billion KRW 23.589%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -121470.381%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW -50.899%
Hanall Biopharma Co.,Ltd 590.3 Million KRW -20868.719%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -1945.955%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW -568.273%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW -883.617%
Hana Pharm Co., Ltd. 1.59 Billion KRW -7641.851%
Yuyu Pharma, Inc. 13.64 Billion KRW -807.477%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -103327.415%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW -2.298%
Aprogen pharmaceuticals,Inc. 32 Billion KRW -286.813%
JW Holdings Corporation 20.65 Billion KRW -499.207%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW -734.933%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW -312.601%
JW Pharmaceutical Corporation 30 Billion KRW -312.601%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -56430.741%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -21217.679%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW -149.716%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW -2680.327%
Yuyu Pharma, Inc. 13.64 Billion KRW -807.477%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW -550.528%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW -32.505%
JW Pharmaceutical Corporation 30 Billion KRW -312.601%
Yuhan Corporation 60.23 Billion KRW -105.5%
Jeil Pharma Holdings Inc 10.5 Billion KRW -1078.86%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW -206.555%
Suheung Co., Ltd. 74 Billion KRW -67.255%
JW Pharmaceutical Corporation 30 Billion KRW -312.601%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW -2870.746%
Korea United Pharm Inc. 10.96 Billion KRW -1029.125%
CKD Bio Corp. 69.43 Billion KRW -78.278%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW -258.008%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW -667.502%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -40211.926%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -56430.741%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW -71.649%
Boryung Corporation 151.7 Billion KRW 18.409%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW -57.631%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -1945.955%
JW Lifescience Corporation 168 Million KRW -73578.735%